Clinical Trial Detail

NCT ID NCT00313599
Title Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Francisco
Indications

lung non-small cell carcinoma

ovarian cancer

Advanced Solid Tumor

prostate cancer

breast cancer

urinary bladder cancer

gastroesophageal junction adenocarcinoma

germ cell cancer

Therapies

Lapatinib + Paclitaxel

Age Groups: adult senior

No variant requirements are available.